Abiopharma

New Form SCHEDULE 13D/A - Compass Therapeutics, Inc. Filed: 2025-08-15 AccNo: 0000947871-25-000785 Size: 23 KB

New Form 8-K - Bluejay Diagnostics, Inc. Filed: 2025-08-15 AccNo: 0001213900-25-077600 Size: 225 KB Item 8.01: Other Events

KUPPUSAMY KARTHIK sold 123.0 shares of QUEST DIAGNOSTICS INC (DGX) at average price $175.91 Filed: 2025-08-15 AccNo: 0001955217-25-000005 Size: 6 KB

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

New Form 8-K - Tonix Pharmaceuticals Holding Corp. Filed: 2025-08-15 AccNo: 0001999371-25-011478 Size: 268 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 144 - QUEST DIAGNOSTICS INC Filed: 2025-08-15 AccNo: 0001959173-25-005254 Size: 25 KB

New Form S-1 - Calidi Biotherapeutics, Inc. Filed: 2025-08-15 AccNo: 0001641172-25-024489 Size: 22 MB

How To Schedule A Text Message To Send Later

New Form 144 - CASTLE BIOSCIENCES INC Filed: 2025-08-15 AccNo: 0001958244-25-004253 Size: 12 KB

New Form 424B3 - SOLIGENIX, INC. Filed: 2025-08-15 AccNo: 0001558370-25-011620 Size: 1 MB

New Form 424B3 - GRI Bio, Inc. Filed: 2025-08-15 AccNo: 0001824293-25-000122 Size: 1 MB

New Form 8-K - SOLIGENIX, INC. Filed: 2025-08-15 AccNo: 0001558370-25-011619 Size: 165 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits

New Form 10-Q/A - VOLITIONRX LTD Filed: 2025-08-15 AccNo: 0001477932-25-005992 Size: 294 KB

New Form 424B3 - SOLIGENIX, INC. Filed: 2025-08-15 AccNo: 0001558370-25-011618 Size: 1 MB

New Form 8-K - BioSig Technologies, Inc. Filed: 2025-08-15 AccNo: 0001641172-25-024484 Size: 747 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits